Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group (Q33426789)

26472661

26 July 2017

title

Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group (English)

1 reference

26 July 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Emmanuelle Bompas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Nicolas Penel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

J Khalifa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Ouali

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

L Chaltiel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Le Guellec

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

P Cousin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

L Chaigneau

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

S Piperno-Neumann

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

B Bui-Nguyen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

M Rios

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

J-P Delord

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

C Chevreau

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

A Le Cesne

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

15 October 2015

1 reference

26 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study.

4 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

A retrospective analysis of antitumour activity with trabectedin in translocation-related sarcomas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Sunitinib malate in solitary fibrous tumor (SFT).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Efficacy of trabectedin in metastatic solitary fibrous tumor.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Brief report: activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Solitary fibrous tumour and haemangiopericytoma: evolution of a concept

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Phase II study of ET-743 in advanced soft tissue sarcomas: a European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: liposarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Chemotherapy of malignant hemangiopericytoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Ecteinascidin-743 (ET-743) for chemotherapy-naive patients with advanced soft tissue sarcomas: multicenter phase II and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

There are no bad anticancer agents, only bad clinical trial designs--twenty-first Richard and Hinda Rosenthal Foundation Award Lecture

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4608145

Conventional hemangiopericytoma

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12885-015-1697-8

Response to chemotherapy of solitary fibrous tumour: A retrospective study

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26472661

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12885-015-1697-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 June 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

26472661

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26472661%20AND%20SRC:MED&resulttype=core&format=json